Bellevue Asset Management, LLC Pulmonx Corp Transaction History

Bellevue Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$15.35 - $23.99 $982 - $1,535	64 New	64 $1,000
Q1 2022 May 11, 2022	SELL	$21.13 - $35.65 $950 - $1,604	-45 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$29.72 - $45.1 $89 - $135	-3 Reduced 6.25%	45 $1,000
Q2 2021 Aug 09, 2021	BUY	$37.61 - $48.0 $300 - $384	8 Added 20.0%	48 $2,000
Q1 2021 May 12, 2021	SELL	$44.0 - $67.54 $44 - $67	-1 Reduced 2.44%	40 $2,000
Q4 2020 Feb 11, 2021	BUY	$39.31 - $69.02 $1,611 - $2,829	41 New	41 $3,000

116

30.6M

400

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $309M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.